Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |